博晖创新：取得医疗器械注册证

Core Viewpoint - The company has received a medical device registration certificate from the National Medical Products Administration for a new in vitro diagnostic reagent, which is expected to enhance its product range and competitive edge in the market [1] Group 1: Product Registration - The product is a nucleic acid testing kit for the detection of rotavirus, norovirus, enteric adenovirus, astrovirus, and sapovirus, using the PCR-fluorescent probe method [1] - The registration classification is Class III, with the registration certificate number being 20253401042, valid from May 29, 2025, to May 28, 2030 [1] Group 2: Market Impact - The acquisition of this registration certificate enriches the company's product offerings, which is beneficial for enhancing its core competitiveness and market expansion capabilities [1] - The new product is significant for the future performance improvement of the company [1]